Heron Therapeutic Inc’s long acting injection Sustol, to prevent chemotherapy induced nausea and vomiting had been twice rejected until finally being approved by the U.S. Food and Drug Administration. This marks the company’s first regulatory approval and boy did investors love the news. Shares rose as much as 21 percent to $24 on Wednesday. Heron’s … Continue reading “Heron (HRTX) Gets Green Light From FDA”
